| scholarly article | Q13442814 |
| P356 | DOI | 10.1084/JEM.146.2.495 |
| P953 | full work available at URL | http://rupress.org/jem/article-pdf/146/2/495/1392975/495.pdf |
| https://europepmc.org/articles/PMC2180764 | ||
| https://europepmc.org/articles/PMC2180764?pdf=render | ||
| P932 | PMC publication ID | 2180764 |
| P698 | PubMed publication ID | 195004 |
| P5875 | ResearchGate publication ID | 270785796 |
| P50 | author | Jack L. Strominger | Q1398103 |
| P2093 | author name string | D. A. Thorley-Lawson | |
| L. Chess | |||
| P2860 | cites work | Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis | Q24632165 |
| Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells | Q34564795 | ||
| Demonstration of a Herpes Group Virus in Cultures of Peripheral Leukocytes from Patients with Infectious Mononucleosis | Q34700495 | ||
| Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus | Q34731769 | ||
| Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis | Q35077262 | ||
| Release of infectious Epstein-Barr virus by transformed marmoset leukocytes | Q35093948 | ||
| Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes | Q36272694 | ||
| Properties of antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. I. In vivo activity and immunochemical characterization | Q36358617 | ||
| Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems | Q36359200 | ||
| Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood | Q36534596 | ||
| Antibodies to early Epstein-Barr virus-induced antigens in Burkitt's lymphoma | Q38895928 | ||
| Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups | Q38896500 | ||
| Comparison between two antibody populations in the EBV system: Anti-MAVersus neutralizing antibody activity | Q39076997 | ||
| Epstein-barr virus-induced transformation of human leukocytes after cell fractionation | Q39323315 | ||
| Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells | Q39392937 | ||
| Pathogenesis and phenotypes of an X-linked recessive lymphoproliferative syndrome | Q39404941 | ||
| Immunologic functions of isolated human lymphocyte subpopulations. III. Specific allogeneic lympholysis mediated by human T cells alone | Q39727734 | ||
| Cell relationships in transformation of human leukocytes by Epstein-Barr virus | Q39903707 | ||
| Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoid cell lines and in the blood of patients with infectious mononucleosis | Q39920743 | ||
| Different Ly antigen phenotypes of in vitro induced helper and suppressor cells | Q44226332 | ||
| Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis | Q45820119 | ||
| Occurrence of Epstein-Barr virus genomes in human lymphoblastoid cell lines | Q45820570 | ||
| Prevalence, incidence and persistence of EB virus antibody in young adults | Q45822766 | ||
| Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines | Q45826585 | ||
| Macrophage-mediated cytotoxicity against allogeneic target cells in vitro | Q68499423 | ||
| Surface markers on human B and T lymphocytes. IV. Distribution of surface markers on resting and blast-transformed lymphocytes | Q69367099 | ||
| Independent movement of IgD and IgM molecules on the surface of individual lymphocytes | Q70000742 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| immunology | Q101929 | ||
| lymphocyte | Q715347 | ||
| dysplasia | Q1128996 | ||
| P304 | page(s) | 495-508 | |
| P577 | publication date | 1977-08-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes | |
| P478 | volume | 146 |
| Q37997650 | A New Approach to the Study of Human B Lymphocyte Function Using an Indirect Plaque Assay and a Direct B Cell Activator |
| Q40219253 | A distinctive pattern of B cell immaturity in perinatal humans |
| Q40262058 | A virus-free immunogen effective against Epstein-Barr virus |
| Q35209798 | Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis |
| Q36852680 | Abrogation of simian virus 40 DNA-mediated transformation of primary C57BL/6 mouse embryo fibroblasts by exposure to a simian virus 40-specific cytotoxic T-lymphocyte clone |
| Q37185460 | Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells |
| Q45752119 | Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts. |
| Q45803516 | Altered regulation of epstein-barr virus induced lymphoblast proliferation in rheumatoid arthritis lymphoid cells |
| Q41200381 | An Epstein-Barr virus immortalization associated gene segment interferes specifically with the IFN-induced anti-proliferative response in human B-lymphoid cell lines |
| Q36367270 | An Epstein-Barr virus-associated superantigen |
| Q41525019 | An RFLP map for 2q33-q37 from multicase mycobacterial and leishmanial disease families: no evidence for an Lsh/Ity/Bcg gene homologue influencing susceptibility to leprosy. |
| Q67486034 | Analysis of Monoclonal Rheumatoid Factors obtained from the B‐Cell Repertoire in Rheumatoid Arthritis |
| Q36347266 | Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation |
| Q45797418 | Analysis of transformation with epstein-barr virus and phenotypic characteristics of lymphoblastoid cell lines established from patients with hairy cell leukemia |
| Q69362165 | Antibodies to Epstein-Barr viral antigens in familial rheumatoid arthritis |
| Q33899614 | Antiviral cell-mediated immune responses and effect of chromosome polymorphism in Herpesvirus saimiri-infected monkeys. |
| Q35885043 | Autoimmune diseases: immunopathology and etiopathogenesis |
| Q41561745 | Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts. |
| Q40138351 | Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes |
| Q41635093 | Characteristics of Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease and age-matched controls |
| Q40209275 | Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells |
| Q70157576 | Characterization of the suppressor activity in lymphocytes from patients with common variable hypogammaglobulinemia: Evidence for an associated primary B-cell defect |
| Q45802718 | Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein–Barr virus-induced B-cell lines |
| Q33556764 | Cytotoxic mechanisms in vitro against Epstein-Barr virus infected lymphoblastoid cell lines in rheumatoid arthritis |
| Q37277265 | Decreased oxygen radical generation by neutrophils from patients with measles presumably owing to activation of suppressor T lymphocytes |
| Q33556770 | Defective Epstein-Barr virus specific suppressor T cell function in progressive systemic sclerosis |
| Q41157263 | Deficient control of in vitro Epstein-Barr virus infection in patients with ankylosing spondylitis |
| Q45775841 | Detection of Epstein-Barr virus (EBV) DNA by the polymerase chain reaction (PCR) in oral smears from healthy individuals and patients with squamous cell carcinoma |
| Q36356442 | Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome |
| Q42125132 | Differential immunological response of patients with rheumatoid arthritis towards two different Epstein-Barr virus strains: inhibition of interleukin-1 release by the B95-8, but not the P3HR-1 virus strain |
| Q36306923 | Dimer-size DNA circles in a leukemic cell immortalized with the Epstein-Barr virus |
| Q38596333 | EBV-Specific Immune Response: Early Research and Personal Reminiscences |
| Q42937446 | Early events in Epstein-Barr virus infection provide a model for B cell activation |
| Q53491576 | Effect of TGF‐β1 on the ebv‐induced transformation of human lymphocyte cultures |
| Q45796698 | Effects of monoclonal antibodies against lymphocyte surface antigens on interleukin 2 excretion by Epstein-Barr virus-specific human T-cell hybridomas |
| Q40204070 | Enhanced induction of growth of B lymphoblasts from fresh human blood by primate type-C retroviruses (gibbon ape leukemia virus and simian sarcoma virus) |
| Q40131366 | Epstein-Barr Virus Antigens–A Challenge to Modern Biochemistry |
| Q40078370 | Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patients |
| Q70210213 | Epstein-Barr virus and rheumatoid arthritis |
| Q38211091 | Epstein-Barr virus and rheumatoid arthritis: cellular and molecular aspects |
| Q39494552 | Epstein-Barr virus infection and immunoregulation in man. |
| Q39539246 | Epstein-Barr virus infections in the X-linked recessive lymphoproliferative syndrome |
| Q35239753 | Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences |
| Q36904686 | Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. |
| Q39781753 | Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma |
| Q43864016 | Epstein-Barr virus-specific cytotoxic T cell responses in rheumatoid arthritis patients |
| Q45805778 | Epstein-Barr-virus-induced lymphoproliferative disorder converting to fatal Burkitt-like lymphoma in a boy with interferon-inducible chromosomal defect |
| Q44452775 | Epstein-barr virus-induced lymphoma in a cardiac transplant recipient |
| Q77148190 | Establishing lymphoblastoid cell lines from frozen blood of extremely old individuals |
| Q36346568 | Establishment of long-term monocyte suspension cultures from normal human peripheral blood |
| Q70160327 | Establishment of spontaneously outgrowing lymphoblastoid cell lines with Cyclosporin A |
| Q36343938 | Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses |
| Q41719620 | Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures |
| Q34420983 | Functional characterization of infiltrating T lymphocytes in human hepatic allografts |
| Q45229606 | Functional properties of continuously cultured human T lymphocytes |
| Q34334755 | Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein |
| Q34616225 | Genetic linkage of Werner's syndrome to five markers on chromosome 8 |
| Q30500345 | Genetics of neoplasia--impact of ecogenetics on oncogenesis. A review |
| Q45835799 | Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A. |
| Q36988786 | Hypothesis: the pathogenesis of AIDS. Activation of the T- and B-cell cascades |
| Q36923500 | Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo |
| Q45799762 | Immature B cells in fetal development and immunodeficiency: Studies of IgM, IgG, IgA and IgD production in vitro using epstein-Barr virus activation |
| Q36669953 | Immune regulation in Epstein-Barr virus-associated diseases |
| Q34415907 | Immunodominant CD8 T cell response to Epstein-Barr virus |
| Q45798960 | Immunoglobulin production by tonsil lymphocytes before and after Epstein-Barr virus transformation |
| Q45800435 | Immunoglobulin properties of Epstein-Barr virus transformed human umbilical cord and adult peripheral blood lymphocytes |
| Q41552231 | Immunopathology of the X-Linked Lymphoproliferative Syndrome |
| Q40734911 | Impaired T lymphocyte colony formation in infectious mononucleosis: evidence for both monocyte and lymphocyte defects |
| Q45851141 | In vitro analysis of Epstein-Barr virus: host balance in patients with acute Plasmodium falciparum malaria. I. Defective T-cell control |
| Q36342050 | In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects |
| Q40237457 | Induction of plaque-forming cells in human blood lymphocytes cultured in the presence of antigen and Epstein-Barr virus: a study with normal donors and infectious mononucleosis patients |
| Q37410691 | Induction of therapeutic antibodies by vaccination against external loops of tumor-associated viral latent membrane protein |
| Q36349693 | Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis |
| Q40189656 | Long-term T-cell-mediated immunity to epstein-barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes |
| Q39905662 | Lymphocyte subpopulations in man: suppression of PWM-induced B-cell proliferation by infectious mononucleosis T cells |
| Q44404400 | Lymphoma, Immunodeficiency and the Epstein-Barr Virus |
| Q45801399 | Mechanism of enhancement of epstein-barr virus-induced transformation of peripheral blood lymphocytes by a tumor promoter, tpa, with special reference to lowering of cytotoxicity of t cells |
| Q34533784 | Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell l |
| Q40132201 | Mechanisms of Viral Tumorigenesis |
| Q40125033 | Molecular theology, immunophilosophy, and autoimmune disease. II. Speculation on the aetiology and pathogenesis of rheumatoid arthritis |
| Q36406027 | Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity |
| Q40101876 | Natural Cell-Mediated Immunity During Viral Infections |
| Q36829599 | Negative modulation of Epstein-Barr virus episomes by a human B-cell growth factor |
| Q36987928 | Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement |
| Q34262343 | Oligoclonal T cell receptor gene rearrangements in blood lymphocytes of patients with acute Epstein-Barr virus-induced infectious mononucleosis |
| Q37001473 | Physiologic concentrations of normal human plasma lipoproteins inhibit the immortalization of peripheral B lymphocytes by the Epstein-Barr virus |
| Q42935418 | Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis |
| Q40119582 | Possibility of EB virus preferentially transforming a subpopulation of human B lymphocytes |
| Q37097273 | Prevention of Epstein-Barr virus-induced B-cell outgrowth by interferon alpha |
| Q70428120 | Production of human immune interferon (Hu IFN-gamma) studied at the single cell level. Origin, evidence for spontaneous secretion and effect of cyclosporin A |
| Q41413485 | Proliferation of hematopoietic cell lines induced by a soluble factor derived from human squamous cell carcinomas of the head and neck |
| Q42723067 | Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity |
| Q34302702 | Rheumatoid arthritis--a virus disease? |
| Q69532019 | Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia |
| Q40188720 | Stimulation of human peripheral blood lymphocytes by autologous EBV-infected B cells |
| Q40158502 | Stimulation of peripheral human lymphocytes by autologous EBV genome-carrying lymphoblastoid cell lines |
| Q53559914 | Studies on the relationship between HLA DR4 and in vitro IgM rheumatoid factor production |
| Q39805019 | Suppressor Cells: Permitters and Promoters of Malignancy? |
| Q34553140 | Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis |
| Q38665396 | Synthetic T and B cell recognition sites: implications for vaccine development |
| Q33560806 | T cell cytotoxicity to Epstein-Barr virus infected B cells: comparison of patients with rheumatoid arthritis and their HLA identical siblings |
| Q45796405 | T-lymphocyte subset interactions in the cell-mediated immune response to Epstein-Barr virus |
| Q38031277 | The Molecular Biology of Lymphotropic Herpesviruses |
| Q33557056 | The abnormal cytotoxic T cell response to Epstein-Barr virus in rheumatoid arthritis is correlated with disease activity and occurs in other arthropathies |
| Q40273259 | The relation between epstein-barr virus antibodies and clinical symptomatology and immunodeficiency in patients with Hodgkin's disease |
| Q68795615 | The role of receptors for complement in the induction of polyclonal B-cell proliferation and differentiation |
| Q45801895 | Three Phases in Transformation of Human Lymphocytes by Epstein-Barr Virus, as Revealed by Colony Formation in Soft Agar |
| Q45142742 | Transformation of lymphocytes by Epstein-Barr virus requires only one-fourth of the viral genome |
| Q36901884 | Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same gene |
| Q28776748 | Virus-encoded superantigens |
| Q45805567 | Virus-immune cytotoxic T cells recognize structural differences between serologically indistinguishable HLA-A2 molecules |
Search more.